The estimated Net Worth of Todd A Trapp is at least $9.47 Milione dollars as of 5 January 2022. Mr. Trapp owns over 1,000 units of Abiomed stock worth over $5,358,284 and over the last 10 years he sold ABMD stock worth over $1,040,453. In addition, he makes $3,073,190 as Chief Financial Officer e Vice President at Abiomed.
Todd has made over 2 trades of the Abiomed stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of ABMD stock worth $359,430 on 5 January 2022.
The largest trade he's ever made was selling 8,975 units of Abiomed stock on 15 February 2018 worth over $681,023. On average, Todd trades about 356 units every 51 days since 2015. As of 5 January 2022 he still owns at least 14,063 units of Abiomed stock.
You can see the complete history of Mr. Trapp stock trades at the bottom of the page.
Todd A. Trapp serves as Chief Financial Officer, Vice President of the Company. Mr. Trapp was appointed as our Vice President and Chief Financial Officer on April 9, 2018. He currently oversees the Finance, IT and Human Resources functions. From April 2015 to March 2018, Mr. Trapp served as Chief Financial Officer of Watts Water Technologies, Inc., where he was responsible for the global finance and IT operations. Prior to joining Watts Water Technologies, Mr. Trapp spent 13 years in a variety of financial and operational roles at Honeywell International Inc., including as Vice President of Global Financial Planning and Analysis, Chief Financial Officer of the Airlines Business Unit, Director of Finance for the Transportation Systems Business Group, Investor Relations Manager and other finance management positions. Prior to joining Honeywell, Mr. Trapp held several treasury and finance operational roles at United Business Media, Inc. and Pearson Inc. Mr. Trapp received his Bachelor of Science in Accounting from Providence College and his Master of Business Administration in Finance from Northeastern University. He is also Six Sigma Green Belt certified.
As the Chief Financial Officer e Vice President of Abiomed, the total compensation of Todd Trapp at Abiomed is $3,073,190. There are 1 executives at Abiomed getting paid more, with Michael Minogue having the highest compensation of $16,612,800.
Todd Trapp is 49, he's been the Chief Financial Officer e Vice President of Abiomed since 2018. There are 15 older and 2 younger executives at Abiomed. The oldest executive at Abiomed Inc. is Jeannine Rivet, 72, who is the Independent Director.
Todd's mailing address filed with the SEC is C/O ABIOMED, INC., 22 CHERRY HILL DR, , DANVERS, MA, 01923.
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose e David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: